Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 3
1988 2
1989 1
1990 5
1991 1
1992 1
1993 5
1994 8
1996 5
1997 10
1998 6
1999 14
2000 8
2001 9
2002 9
2003 8
2004 7
2005 11
2006 9
2007 2
2008 7
2009 10
2010 8
2011 14
2012 22
2013 23
2014 12
2015 11
2016 15
2017 21
2018 13
2019 9
2020 12
2021 14
2022 14
2023 12
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study.
Basu P, Malvi SG, Joshi S, Bhatla N, Muwonge R, Lucas E, Verma Y, Esmy PO, Poli URR, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Prabhu PR, Kannan TPRA, Varghese R, Shastri SS, Anantharaman D, Gheit T, Tommasino M, Sauvaget C, Pillai MR, Sankaranarayanan R. Basu P, et al. Among authors: pillai mr. Lancet Oncol. 2021 Nov;22(11):1518-1529. doi: 10.1016/S1470-2045(21)00453-8. Epub 2021 Oct 8. Lancet Oncol. 2021. PMID: 34634254 Free PMC article.
Targeted radionuclide therapy--an overview.
Dash A, Knapp FF, Pillai MR. Dash A, et al. Among authors: pillai mr. Curr Radiopharm. 2013 Sep;6(3):152-80. doi: 10.2174/18744710113066660023. Curr Radiopharm. 2013. PMID: 24059327 Review.
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine.
Bhatla N, Muwonge R, Malvi SG, Joshi S, Poli URR, Lucas E, Esmy PO, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Vashist S, Mishra G, Jadhav R, Siddiqi M, Anantharaman D, Panicker G, Butt J, Sankaran S, Kannan TPRA, Varghese R, Kartha P, Pillai MR, Waterboer T, Müller M, Sehr P, Unger ER, Sankaranarayanan R, Basu P. Bhatla N, et al. Among authors: pillai mr. Hum Vaccin Immunother. 2023 Dec 15;19(3):2289242. doi: 10.1080/21645515.2023.2289242. Epub 2023 Dec 11. Hum Vaccin Immunother. 2023. PMID: 38078840 Free PMC article.
Dengue vaccine development: strategies and challenges.
Ramakrishnan L, Pillai MR, Nair RR. Ramakrishnan L, et al. Among authors: pillai mr. Viral Immunol. 2015 Mar;28(2):76-84. doi: 10.1089/vim.2014.0093. Epub 2014 Dec 10. Viral Immunol. 2015. PMID: 25494228 Review.
Peptide receptor radionuclide therapy: an overview.
Dash A, Chakraborty S, Pillai MR, Knapp FF Jr. Dash A, et al. Among authors: pillai mr. Cancer Biother Radiopharm. 2015 Mar;30(2):47-71. doi: 10.1089/cbr.2014.1741. Epub 2015 Feb 24. Cancer Biother Radiopharm. 2015. PMID: 25710506 Review.
RTKs in pathobiology of head and neck cancers.
Nadhan R, Srinivas P, Pillai MR. Nadhan R, et al. Among authors: pillai mr. Adv Cancer Res. 2020;147:319-373. doi: 10.1016/bs.acr.2020.04.008. Epub 2020 Jun 15. Adv Cancer Res. 2020. PMID: 32593405 Review.
Signaling coupled epigenomic regulation of gene expression.
Kumar R, Deivendran S, Santhoshkumar TR, Pillai MR. Kumar R, et al. Among authors: pillai mr. Oncogene. 2017 Oct 26;36(43):5917-5926. doi: 10.1038/onc.2017.201. Epub 2017 Jun 26. Oncogene. 2017. PMID: 28650470 Review.
Mina: a Th2 response regulator meets TGFβ.
Pillai MR, Lian S, Bix M. Pillai MR, et al. Curr Opin Immunol. 2014 Dec;31:38-43. doi: 10.1016/j.coi.2014.09.005. Epub 2014 Oct 1. Curr Opin Immunol. 2014. PMID: 25282476 Free PMC article. Review.
Impact of HPV vaccination on HPV-related oral infections.
Gheit T, Muwonge R, Lucas E, Galati L, Anantharaman D, McKay-Chopin S, Malvi SG, Jayant K, Joshi S, Esmy PO, Pillai MR, Basu P, Sankaranarayanan R, Tommasino M. Gheit T, et al. Among authors: pillai mr. Oral Oncol. 2023 Jan;136:106244. doi: 10.1016/j.oraloncology.2022.106244. Epub 2022 Nov 16. Oral Oncol. 2023. PMID: 36402055 Free PMC article.
327 results